PCI Biotech Holding ASA 2023 Annual Report with Sustainability Disclosures
Company: PCI Biotech Holding ASA
Sector: Manufacturing
Country: Norway
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 51
The report describes PCI Biotech as a small, pre-commercial biopharmaceutical Group with 7 employees at year-end 2023. Its principal development focus was photochemical lysis (PCL) technology intended to improve yield and reduce impurities in viral-vector manufacturing, supported by field testing with a European partner. The report also states that the Group had no revenues and no significant environmental impact beyond normal operations, while identifying travel and shipments as its main environmental-impact activities. Sustainability reporting was integrated into the CSR section and used no specific sustainability reporting standard other than the Norwegian corporate-governance Code.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.